Forte Biosciences (FBRX) Misses Q2 EPS by 96c

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.96).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2 calls to 1 put into quarter results
• ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
• Activist investor presses Xerox to review financial services arm - Bloomberg